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ABSTRACT
Isocitrate dehydrogenase (IDH) is an enzyme required for the
production of α-ketoglutarate from isocitrate. IDH3 generates the
NADH used in the mitochondria for ATP production, and is a tetramer
made up of two α, one β and one γ subunit. Loss-of-function and
missense mutations in both IDH3A and IDH3B have previously been
implicated in families exhibiting retinal degeneration. Using mouse
models, we investigated the role of IDH3 in retinal disease and
mitochondrial function. We identified mice with late-onset retinal
degeneration in a screen of ageing mice carrying an ENU-induced
mutation, E229K, in Idh3a. Mice homozygous for this mutation exhibit
signs of retinal stress, indicated by GFAP staining, as early as
3 months, but no other tissues appear to be affected. We produced a
knockout of Idh3a and found that homozygous mice do not survive
past early embryogenesis. Idh3a−/E229K compound heterozygous
mutants exhibit a more severe retinal degeneration compared with
Idh3aE229K/E229K homozygous mutants. Analysis of mitochondrial
function in mutant cell lines highlighted a reduction in mitochondrial
maximal respiration and reserve capacity levels in both
Idh3aE229K/E229K and Idh3a−/E229K cells. Loss-of-function Idh3b
mutants do not exhibit the same retinal degeneration phenotype,
with no signs of retinal stress or reduction in mitochondrial respiration.
It has previously been reported that the retina operates with a limited
mitochondrial reserve capacity and we suggest that this, in
combination with the reduced reserve capacity in mutants, explains
the degenerative phenotype observed in Idh3a mutant mice.
This article has an associated First Person interview with the first
author of the paper.
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INTRODUCTION
Mitochondrial diseases are highly diverse: over 220 different genes
have been identified that can cause diseases of the mitochondria, and
these diseases have a wide range of pathologies (Koopman et al.,
2012). Common to many of the diseases, however, are neurological
or neuromuscular manifestations, including retinal disease. We have
identified a missense mutation in the gene encoding a subunit of the
tricarboxylic acid (TCA) cycle enzyme isocitrate dehydrogenase 3
(IDH3) as causing a retinal degeneration phenotype in mice. There
are three isocitrate dehydrogenase isozymes in mammals. IDH1 and
IDH2 are both homodimers that catalyse the decarboxylation of
isocitrate to α-ketoglutarate with the concomitant reduction of NADP
to NADPH. IDH1 is cytoplasmic, whereas IDH2 is localised to the
mitochondria. No inherited disease has been associated with IDH1
mutations, but mutations in IDH2 cause a metabolic disease, D-2-
hydroxyglutaric aciduria, with a range of features including epilepsy,
hypotonia and other neurological manifestations (Kranendijk et al.,
2010). IDH1 or IDH2 has been found to be mutated in a high
proportion of glioblastomas and other tumours of the nervous system.
By contrast, IDH3 is a heterotetramer, composed of two α, one β and
one γ subunit, encoded by three genes. IDH3 is located in the
mitochondria, where the conversion of isocitrate to α-ketoglutarate is
necessary for the TCA cycle to progress and generate NADH, which
feeds into oxidative phosphorylation to generate ATP. No recurrent
mutations in any of the IDH3 genes have been described in tumours.
A number of patients have been described with a variety of
mutations in IDH3A (Fattal-Valevski et al., 2017; Pierrache et al.,
2017).Apatientwith themost severe of these, a homozygousmissense
mutation (p.Pro304His), exhibited neurological defects from birth,
possibly due to a failure during development, as well as retinal
degeneration. However, the patient showed no symptoms of muscle
weakness, typically associated with mitochondrial deficiencies. The
remaining patients, with bi-allelic variants, all exhibited childhood
onset of retinal degeneration and some had pseudocoloboma of the
macula. Pseudocoloboma is not a developmental defect but is caused
by degeneration of the retina. Seven different alleleswere found in four
different families all predicted to be pathogenic, including two that
could potentially cause nonsense-mediated decay. The other five,
all missense mutations, are anticipated to be damaging. Two families
with homozygous mutations in IDH3B, and which exhibited
non-syndromic retinal degeneration, have also been described
(Hartong et al., 2008). None of these patients showed symptoms of
mitochondrial dysfunction other than retinitis pigmentosa (RP).
We have identified a missense mutation, E229K, in mouse
Idh3a, which is associated with late-onset retinal degeneration. In
addition, we generated a complete loss-of-function mutation in
this gene and show that it is early embryonic lethal. This mutation,
when combined with the missense mutation Idh3aE229K, results
in a more rapid retinal degeneration than that in the missense
homozygotes. Photoreceptors of the retina have a particularly
high energy requirement, and the mitochondria of these cells
function at 70-80% of their maximal rate, leaving limited reserveReceived 9 July 2018; Accepted 12 November 2018
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capacity (Kooragayala et al., 2015). This most likely accounts
for the sensitivity of the retina to mitochondrial mutations. On the
other hand, a loss-of-function mutation in Idh3b is viable and
has no detectable abnormal phenotype. The retina of these mice
are normal up to 6 months of age. We have analysed the
mitochondrial function in cells with Idh3 mutations, and find the
maximum and reserve capacity of Idh3a mutant cells to be
reduced. However, cells lacking IDH3B show no detectable
mitochondrial defect.
RESULTS
Following a screen for N-ethyl-N-nitrosourea (ENU)-induced
recessive mutations with an age-dependent phenotype, we
identified a mouse line that exhibited loss of vision and retinal
degeneration associated with increasing age (Potter et al., 2016).
When subjected to a moving visual stimulus within an optokinetic
drum (OKD) at 12 months of age, a subset of the littermates in this
cross responded with the stereotypical head movement only at ∼0.2
cycles per degree (c/d), compared with >0.3 c/d for phenotypically
wild-type littermates. These mice maintained a diminished response
at 18 months (Fig. 1A). The same mice had abnormal retina,
identified by indirect ophthalmoscopy and documented by fundal
imaging at 7 months (Fig. 1B). The dark patches on the retinal
images are indicative of retinal degeneration. No other overt
phenotypes were detected in the mice up to 18 months of age
(Table S1).
Genotyping of the affected littermates in this cross revealed a
single common region of homozygosity on chromosome 9, between
50.1 Mb and 74.8 Mb. Analysis of whole-genome sequence of the
founder male for this line found two candidate protein coding
mutations in the interval, heterozygous in the founder: sorting nexin
33 (Snx33) and the α subunit of isocitrate dehydrogenase 3 (Idh3a).
The Snx33 mutation was not present in the mutant line, presumably
because it is on the unaffected chromosome. We considered the
missense mutation, E229K, in Idh3a to be the likely causative
mutation, as human patients with mutations in either IDH3A or
IDH3B exhibit retinal degeneration (Fattal-Valevski et al., 2017;
Hartong et al., 2008; Pierrache et al., 2017). To confirm Idh3a as the
causative gene, we used CRISPR/Cas9 to introduce a loss-of-
function mutation. We generated an insertion of 5 bp into exon 7 of
the gene, c.702_703InsGTACT, termed Idh3aem1Jkn, abbreviated
herein as Idh3a−.
We bred compound heterozygous mice for Idh3a− and Idh3aE229K
and examined their eyes and visual function. As documented below,
these mice have rapid retinal degeneration, demonstrating lack of
complementation between the two alleles, and indicating that the
E229Kmutation is the cause of retinal degeneration in themice found
in the screen.
Fig. 1. Idh3aE229K/E229K mice exhibit signs of
retinal degeneration. (A) Idh3aE229K/E229Kmice (red)
showed a decline in visual acuity, as determined
by optokinetic drum (OKD) score, by 12 months
{0.2071±0.01872 c/d [mean±s.e.m., n=9, female
(F) 4, male (M) 5]} compared with wild-type (blue)
[0.3090±0.009441 c/d (mean±s.e.m., n=23,
F14, M9)] (P<0.0001) and heterozygous (yellow)
[0.3173±0.007472 c/d (mean±s.e.m., n=35, F24,
M11)] (P<0.0001) mice. This significant decline
continued and, by 18 months, homozygous mice (red)
had degenerated further [0.1592±0.02396 c/d (mean
±s.e.m., n=9 F4, M5)] compared with wild-type (blue)
[0.3004±0.01223 c/d (mean±s.e.m., n=23, F14, M9)]
(P<0.0001) and heterozygous (yellow) [0.2836
±0.009699 c/d (mean±s.e.m., n=35, F24, M11)] mice
(P<0.0001). Unpaired t-test, ***P<0.001. (B) Fundus
imaging comparing Idh3aE229K/E229K retina with that of
awild-type littermate; themutant retina exhibits signs of
retinal degeneration, as evidenced by a dark patchy
appearance. (C) Structure of the IDH3A:IDH3G
heterodimer (PDB ID: 5GRI) with the positions of
the E229K mutation identified in this study (red)
and previously identified missense mutations (blue)
highlighted. (D) Predicted effects of mutations on the
stability of the IDH3A monomer and on the strength
of the interaction with IDH3G. Higher values
indicate greater disruption of protein stability or
interaction strength.
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Structural analysis of missense mutations
ResidueGlu229 is located at the rim (Levy, 2010) of the heterodimeric
interface formed between IDH3A and IDH3G (Fig. 1C), contributing
only a small amount of surface area (9.7 Å2) to the much-larger
interface (4401 Å2). However, molecular modelling of the E229K
mutation, which replaces a negatively charged side chain with a
positive charge, shows that it is likely to moderately disrupt the
IDH3A:IDH3G interaction with little effect on the stability of the
IDH3A monomer (Fig. 1D). In contrast, all five of the previously
identified damaging IDH3A mutations are located away from the
interface, either in the protein interior (A175V, M239T, P304H,
M313T) or on the protein surface (R316C). All of these mutations are
predicted to destabilise the IDH3A monomer, but not the interaction
with IDH3G.
Loss of Idh3a is lethal
As IDH3 is a critical part of the mitochondrial tricarboxylic acid
(TCA) cycle, we asked whether the loss-of-function insertion allele
was compatible with life. We intercrossed mice carrying the Idh3a−
allele. No homozygous mice were recovered at weaning from a total
of 120 genotyped, indicating that a complete loss of function of Idh3a
is lethal. We examined embryos from intercrosses at different stages.
No homozygous embryos were recovered at embryonic day (E) 10.5
or E12.5. At E8.5, only the remains of developmentally delayed
embryos were recovered, indicating lethality to be early in
development (Table 1). We confirmed loss of function of Idh3a by
western blot analysis of Idh3a−/+ and Idh3a−/E229K mutant mouse
embryonic fibroblasts (MEFs), which showed a reduction in
IDH3A protein when compared with Idh3a+/+, Idh3aE229K/+ and
Idh3aE229K/E229K cell lines (Fig. S1). Heterozygous littermates were
aged to 1 year but no retinal degeneration was observed, indicating
that one functional allele of the gene is sufficient (Fig. S2).
Onset of retinal degeneration is early and rapid
We analysed the onset and progression of the retinal degeneration of
both Idh3aE229K/E229K and Idh3a−/E229K mice by immunostaining
for glial fibrillary acidic protein (GFAP), the expression of which is
a sign of reactive gliosis of the Müller cells and an early indicator of
stress within the retina (Eisenfeld et al., 1984). We also stained
histological sections to assess retinal structure and integrity. From
postnatal day (P) 30, Idh3a−/E229K mice exhibit GFAP staining
throughout the retina (Fig. 2A), highlighting intermediate fibrils
protruding from the ganglion cell layer to the outer nuclei layer
(ONL). Nevertheless, at this stage, Idh3a−/E229Kmice still retain the
same number of nuclei in the ONL (the nuclei of the photoreceptors)
as control littermates (Fig. 2C) throughout almost the entire retina,
with only a slight decrease in the nasal periphery. However, by P60,
the ONL has lost a significant portion of nuclei, indicating a loss of
photoreceptor cells (Fig. 2B). This loss progresses further by P90
(Fig. 2B). No other cells within the retina appear to be lost during
this degeneration.
By contrast, Idh3aE229K/E229K mice up to P60 show no signs of
reactive gliosis or loss of cells (Fig. 2A). It is not until P90 that they
begin to show GFAP staining (Fig. 2A), and the mice begin to lose
photoreceptor nuclei (Fig. 2D). Again, no other cells appear to be
lost during this time.
Prior to the loss of photoreceptors, mice exhibit normal
retinal function
We carried out electroretinogram (ERG) analysis of Idh3a−/E229K
mice at P30. Although some reactive gliosis is detected at this stage,
they nevertheless showed a normal response to light stimulus.
A-wave amplitudes were not significantly different from those of
wild-type and heterozygous (Idh3a−/+ and Idh3aE229K/+)
littermates, as shown by one-way ANOVA [F(3,10)=0.7970,
P=0.5232], and the trace produced shows no abnormalities
(Fig. 3A,C). The same mice tested at P60 showed a significantly
reduced a-wave response, as shown by one-way ANOVA with
Tukey post hoc tests [F(3,9)=32.66, P<0.0001], and mice exhibited
a flatline ERG trace (Fig. 3B,C). The loss of a scotopic response is
concurrent with the loss of photoreceptors observed in Fig. 2B.
The scotopic ERG responses of Idh3aE229K/E229K mice were
tested at P60. Homozygous mutants showed no significant
difference (P=0.9604) from wild-type littermates, showing a
normal a-wave amplitude and trace (Fig. 3D,F). However, by
4 months of age, the a-wave amplitudes of scotopic ERG responses
have significantly reduced in Idh3aE229K/E229K compared with those
of wild-type littermates (P=0.0491, unpaired t-test with Welch’s
correction) (Fig. 3E,F).
Mitochondria show a reducedmaximal and reserve capacity
As IDH3 is an essential part of the mitochondrial TCA cycle, we
investigated how the Idh3amutations affected the overall function of
mitochondria (Fig. 4A). It has previously been shown (Kooragayala
et al., 2015) that photoreceptors have a high oxygen demand and, as a
consequence, their mitochondria are at maximum capacity. In order
to measure the mitochondrial function in cells that are not already at
maximum capacity, we derived multiple, independent fibroblast lines
from Idh3aE229K/E229K and Idh3a−/E229K embryos, and heterozygous
and wild-type littermates. When tested, the homozygous and
compound heterozygous mutant cell lines showed a trend for lower
basal (Fig. 4D), ATP (Fig. 4E) and leaked (Fig. 4F) respiration,
although this trend was not statistically significant. However, both
Idh3aE229K/E229K and Idh3a−/E229K cell lines did exhibit a significant
decrease in maximal respiration (Fig. 4B) and spare respiratory
capacity (Fig. 4C). Spare respiratory capacity (or reserve capacity) is a
direct measure of a cell’s ability to deal with respiratory stress.
Mitochondrial dysfunction can result in cell death due to oxidative
stress. We asked whether the mitochondrial defect in this case led to
an excess of reactive oxygen species in the cells, and found no
difference between mutant and wild-type cells (Fig. S3A, Table S3).
Similarly, we measured the amount of mitochondrial proteins
(Fig. S3B) and all cell lines showed similar amounts, indicating no
change in mitochondrial number.
Idh3bmutants do not exhibit the same phenotype as Idh3a
mutants
As human patients with apparent loss-of-function mutations in
IDH3B seem only to have retinal degeneration, we produced a
CRISPR/Cas9-induced mutation in the mouse Idh3b gene. We
identified an 8 bp deletion allele, c.478_487delCCAATGGA, and
intercrossed carriers of this mutation, here abbreviated to Idh3b−.
Homozygous animals were identified at normal Mendelian ratio.
Protein extracts from homozygous livers were probed on
immunoblots following electrophoresis and no protein could be
detected, indicating that themutation causes a loss of function (Fig. 5F).
Table 1. Genotyping of loss-of-function mutant
Idh3a−/− (n) Idh3a−/+ (n) Idh3a+/+ (n) No. of litters
Weaned 0 76 44 17
E12.5 0 12 6 3
E10.5 0 9 4 2
E8.5 3 8 2 2
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Idh3b−/− mice were aged and analysed in the same manner as
Idh3a mutant mice. By P180, we observed no signs of retinal
degeneration. There was no observed upregulation of GFAP in the
Idh3b−/− mice compared with wild-type littermate controls
(Fig. 5A). ERG analysis showed that homozygous mutants
exhibited normal scotopic responses (Fig. 5B). Extracellular flux
analysis of fibroblasts produced from mutant embryos also showed
that these mutant cell lines’ mitochondria were not affected by the
loss of Idh3b, with normal reserve capacity and maximum
respiration levels (Fig. 5C-E).
DISCUSSION
In this study, we have investigated the retinal degeneration in a
mouse line identified in a recessive ENU screen. This is the first
mouse model of IDH3A-related chronic retinal degeneration
described, and closely mirrors the phenotype observed in patients.
However, is not possible to model the pseudocoloboma of the
macula seen in human patients in mice, as they lack a macula.
Through the course of the investigation, we confirmed the genetic
source of the phenotype to be a missense mutation in the Idh3a
gene. The amino acid mutated in the Idh3aE229Kmouse is within the
highly conserved nucleotide-binding domain observed in both
NAD- and NADP-dependent dehydrogenases of animals, including
Caenorhabditis elegans and Drosophila (Pierrache et al., 2017).
E229 is close to the amino acid critical for binding the divalent
cation necessary for activity (D233), and is within a short segment
of β-sheet (Ma et al., 2017b).
Mutation of such a highly conserved amino acid residue in an
important part of the enzyme might suggest that it would cause
complete loss of function, but the fact that the insertion (null)
mutation is embryonic lethal indicates that the E229K allele is
actually a partial loss-of-function mutation. The human mutations
that have been identified in patients with RP presumably also
include partial loss-of-function alleles. Two mutations are clear
Fig. 2. Idh3a−/E229K and Idh3aE229K/E229K mice
show early and rapid photoreceptor loss. (A) In
Idh3a−/E229K mice, reactive gliosis, as indicated
by green GFAP staining, is present from P30 and
continues through P60-90 (n=3). This staining is
not present in P30-60 Idh3aE229K/E229K, or in P90
wild-type littermates (rightmost), but is seen in P90
Idh3aE229K/E229K retinal sections (n=3). Blue staining
is DAPI. (B) Histological analysis of H&E-stained
eyes. The numbers of nuclei in the ONL are clearly
decreased in Idh3a−/E229K at P60 and almost absent
by P90. (C,D) Numbers of photoreceptor nuclei in the
ONL (y-axis) at fixed distances either side of the optic
nerve head (x-axis). Counts at P30 (C) show that
all genotypes have normal nuclei numbers, except
for the periphery of Idh3a−/E229K retinas (n=3-6, data in
Table S2). By P60 and continuing to P90 (D),
the numbers of nuclei are significantly decreased in
Idh3aE229K/E229K retinas (n=7, F7, M2) compared with
those of wild-type littermate controls (n=7, F4, M3).
Unpaired t-test, *P<0.05, **P<0.01. Scale bars: 50 µm.
INL, inner nuclei layer; ONL, outer nuclei layer; RGC,
retinal ganglion cell layer; RPE, retinal pigmented
epithelium.
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nulls: a frameshift and a stop-gain. Each of these is in a compound
heterozygote with a likely partial loss-of-function mutation: M239C
and R316H. One patient was homozygous for A175V, again
presumed to be a partial loss of function. A further patient was
compound heterozygous for M313T and P304H (Pierrache et al.,
2017). The latter mutation was also identified as homozygous in a
child with severe neurological defects in addition to retinal
degeneration, and thus M313T is another likely partial loss-of-
function allele. The three patients with one clear null allele included
both who had macular pseudocoloboma in addition to RP,
suggesting that it is a further reduction in IDH3A activity that
results in the additional pathology. Notwithstanding the variation in
severity of the mutations, all the mutated amino acids are completely
conserved across animals from mammals to Drosophila and
C. elegans. Structural modelling suggests that all five human
mutations destabilise the protein, and thus we suggest that they cause
severe loss, but not complete absence, of this catalytic subunit.
Mice compound heterozygous for the missense and insertion
mutations exhibited a severe form of retinal degeneration, but have
no other detectable abnormal phenotypes. A single copy of the
Idh3aE229K allele provides sufficient IDH3 function for apparently
normal development and physiology, except in the photoreceptors.
As previously reported (Kooragayala et al., 2015), photoreceptor
cells operate at ∼70-80% of their mitochondria’s maximal capacity,
which means that they have little to no reserve capacity to use when
under metabolic respiratory stress. Idh3aE229K/E229K and
Idh3a−/E229K MEFs have a much lower maximal and reserve
capacity compared with that of control cells. This lowered reserve
capacity of mutant mitochondria, combined with the already
decreased reserve capacity of photoreceptor cells, may explain the
non-syndromic retinal degeneration phenotype observed. Much like
the human patients previously reported, mice with the more severe
allele combined with the missense allele exhibit a more severe form
of degeneration, although extracellular flux analysis shows that cells
have a similar decrease in reserve and maximal respiration.
By using MEF cells, the mitochondrial function of mutant mice
was observed in an unstressed system. Although the mice showed no
overt phenotype other than retinal degeneration, their mitochondria in
MEFs exhibited a significant reduction in spare respiratory capacity.
Reduction in spare respiratory capacity has previously been shown to
induce cell death in both neurons and cardiomyocytes (Pfleger et al.,
2015; Yadava and Nicholls, 2007). This reduction is thought to
induce cell death either by increasing the amount of reactive oxygen
species until a threshold is met and the cells succumb, or by causing a
reduction in the amount of ATP produced by the electron transport
chain, caused by a decrease in the availability of substrates (Sansbury
et al., 2011; Yadava and Nicholls, 2007). Both of these could explain
the degenerative phenotype observed in the Idh3a mutant mice,
withinwhich the catalytic subunit of the IDH3 enzyme has reduced or
partial function.
Fig. 3. Idh3a−/E229K and Idh3aE229K/E229Kmice shownormal then decreased photoreceptor function. (A-C) A-wave amplitudes of dark-adapted Idh3a−/E229K
mice and littermate controls, exposed to a 3 cd/m3 flash of light at P30 (A) and P60 (B), with accompanying traces showing mutant (red) and wild-type (blue)
scotopic responses at P30 (C, top) and P60 (C, bottom). At P30, Idh3a−/E229K mice exhibit a-wave amplitudes comparable to those of control littermates,
as shown by one-way ANOVA [F(3,10)=0.7970, P=0.5232] [n=4 (F2, M2), 3 (F2, M1), 3 (F1, M2), 4 (F2, M2)], but by P60 this has significantly decreased
[F(3,9)=32.66, ***P<0.001] [n=3 (M3), 3 (F1, M2), 3 (F1, M2), 5, (F1, M4)]. (D,E) Comparison of a-wave amplitudes between Idh3aE229K/E229K and wild-type
controls at P60 (D) and P120 (E), respectively. At P60, mutant mice exhibit no loss of retinal function [265.5±18.18 (mean±s.e.m., n=5, F2, M3)] compared with
wild-type littermates [267.0±21.3 (mean±s.e.m., n=4, F4)]. By P120, photoreceptor response to a light stimulus is significantly reduced in mutant [153.2±35.11
(mean±s.e.m., n=4, F2, M2)] compared with wild-type [247.7±15.51 (mean±s.e.m., n=4, F3, M1)] mice. *P<0.05. (F) Accompanying traces show Idh3aE229K/E229K
(green) and wild-type control traces (blue) at P30 (top) and P120 (bottom).
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The presence of more than one IDH enzyme within the
mitochondria has been used as evidence for redundant function, and
the viability of human patients apparently lacking IDH3B function led
others to suggest that it is IDH2 that is the main TCA cycle enzyme in
all tissues except the retina (Hartong et al., 2008). As we have shown
that loss of Idh3a is lethal early in development, it is clear that IDH2
cannot compensate, and it is the difference between loss of the
catalytic subunit and the regulatory subunit that that results in the
different outcomes. Furthermore, we used RT-PCR to confirm the
expression of Idh2 in the mouse retina, as well as all three subunits of
Idh3 (Fig. S1), indicating that it is not lack of IDH2 in the retina that
results in retinal degeneration. On the other hand, when Idh3a activity
was knocked down in INS-1 832/13 beta cells, glucose-dependent
production of α-ketoglutarate was greater than that when both Idh3a
and Idh2were knocked down (MacDonald et al., 2013). This indicates
that IDH2 can at least partially make up for the loss of IDH3 in this
assay. A compensatorymechanism for loss of IDH3 potentially would
be the conversion of NADPH, produced by IDH2, to NADH by the
enzyme nicotinamide nucleotide transhydrogenase (NNT) (Hoek and
Rydström, 1988). This NADH would then be able to participate in
oxidative phosphorylation as normal. Furthermore, the gene encoding
NNT is mutated in the C57BL6/J strain (Mekada et al., 2009).
However, we bred the mice in this study with C57BL6/N, with a
normalNnt gene, before backcrossing and selecting study animals that
did not have the mutantNnt gene. The lethality of the Idh3a knockout
allele indicates that NNT is unable to enable compensation in vivo.
In contrast to Idh3a mutants, Idh3b mutant mice are fully viable
and show no signs of retinal degeneration within 6 months of age.
Histology and ERG analysis show no significant loss of retinal
structure or function. This is also shown in the results of
extracellular flux analysis whereby Idh3b mutant MEFs do not
show compromised mitochondrial activity. The human patients
with clear null mutations in IDH3B develop RP in adulthood; the
mutant mice might not live long enough to develop retinal
degeneration, or this might simply reflect species differences.
Species differences in response to enzymatic dysfunction could
also, of course, impact the phenotype of the Idh3amutations. The α
subunit of IDH3, encoded by Idh3a, is responsible for the catalytic
activity (Bzymek and Colman, 2007). The α subunit alone is
inactive and requires the β and γ subunits, encoded by Idh3b and
Idh3g. Dimers of αγ or αβ have activity, but vary greatly in their
properties. In vitro, αγ dimers have 36% the specific activity of the
Fig. 4. Mutant MEF cells exhibit reduced reserve and
maximal respiration. Idh3a mutants exhibit reduced
mitochondrial maximum respiration and reserve capacity.
(A) Oxygen consumption (OCR) of MEF cells was measured
using an Agilent Seahorse XFe24 Extracellular Flux Analyser
in basal and stimulated conditions. (B-F) Histograms show
maximal respiration [FCCP measurement 2 – antimycin+
rotenone (Ant/Ret) measurement 2] (B), reserve capacity
(FCCP measurement 2 – basal measurement 2) (C), basal
respiration (basal measurement 2 – Ant/Ret measurement 2)
(D), ATP respiration (basal measurement 2 – oligo
measurement 2) (E), leaked respiration (oligo measurement
2 – Ant/Ret measurement 2) (F) pmol min−1 OD540−1 for each
part of the experiment (A). Idh3a−/E229K and Idh3aE229K/E229K
mutant cells show a lower, but not significant, trend in basal,
ATP-dependent or leaked respiration compared with wild type
(D-F). Both Idh3a−/E229K and Idh3aE229K/E229K showed
significantly reduced maximum respiration [F(4,10)=5.701,
P=0.0118] (B) and spare respiratory capacity [F(4,10)=6.536,
P=0.0075] (C), as shown by one-way ANOVA. *P<0.05,
**P<0.01.
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heterotetramer, whilst αβ dimers have only 16%. Furthermore, αγ
dimers are activated at low concentrations of ATP, whereas αβ
dimers are inhibited. The substrate, isocitrate, activates both the
heterotetramer and the αγ dimers, but has no effect on the αβ dimers
(Ma et al., 2017b). We believe that the catalytic activity of the αγ
heterodimers explains the lack, or perhaps delay, of a degenerative
phenotype in Idh3b mutant mice. This also explains why loss-of-
function IDH3B patients exhibit milder symptoms and at a much
later age than patients with IDH3A mutations. In addition, the
E229K mutation we describe here is likely to be interfering with the
α/γ interaction, indicating that this is important for full activity.
Mutation of many different mitochondrial protein-coding genes can
each lead to inherited diseases, with a range of phenotypes. Although
there are some common phenotypic consequences, principally
neurological manifestations, there is no clear pattern that can predict
the outcome of a particular gene mutation (Munnich, 2008; Rustin
et al., 1997). Even amongst genes of the TCA cycle, there is a range of
consequences. Some mutations in the mitochondrial aconitase gene
(ACO2), similar to IDH3A, can result in severe neurological disease,
progressive optic atrophy and retinal degeneration (Metodiev et al.,
2014), whilst other mutations in the same gene can give optic atrophy
only. Progressive neurodegenerative disease also arises from
mutations in the gene for the TCA cycle enzyme α-ketoglutarate
dehydrogenase. Succinate dehydrogenase (SDHA) mutations not
only can result in the severe neurological disorder Leigh
Syndrome, but also in one extended family can cause dilated
cardiomyopathy (Rustin et al., 1997). Mutations in the gene for
another succinate dehydrogenase subunit (SDHD) are also a cause
of encephalomyopathy (Rustin et al., 1997). Muscle involvement in
addition to neurological disease is also seen inmutations of themalate
dehydrogenase gene, MDH2 (Ait-El-Mkadem et al., 2017).
The high-energy demand of the nervous system, and in particular
the retina, makes these cells particularly sensitive to deficiencies in
mitochondrial function. In our novel mouse models, we show that
total loss of the TCA cycle enzyme IDH3 is early embryonic lethal,
indicating that the mitochondrial enzyme IDH2 cannot compensate.
However, partial loss of function, modelling human patients, results
only in retinal degeneration. Modelling human patient mutations in
which Idh3b, the regulatory subunit of IDH3, is absent does not result
in retinal degeneration in mice within 6 months of age, reflecting the
later onset of RP in the patients. The mechanism of cell death in this
and other mitochondrial retinopathies is not fully understood, and it
remains to be addressed whether therapeutic options exist.
MATERIALS AND METHODS
Mice
Idh3ampc201H, denoted as Idh3aE229K, mice were produced in a recessive
ENU screen at MRC Harwell (Potter et al., 2016). Idh3aem1Jkn mice were
made by microinjection of nuclear CRISPR/Cas9 nickase vectors px335
(Addgene), together containing two guide RNAs (gRNAs) targeting exon 7
(Table 2) to minimise off-target effects. Sequencing identified a 5 bp
insertion mutation, c.702_703InsGTACT, in the gene.
Idh3bem1Jknmiceweremade bymicroinjection ofCRISPRgRNA targeting
exon 5 and Cas9 protein into the pronucleus of fertilised eggs (Table 2).
Sequencing identified an 8 bp deletionmutation, c.478_487delCCAATGGA,
in the gene. gRNAs were chosen with low off-target predictions and mice
were backcrossed onto C57BL6/J prior to breeding. All animal work was
approved by a University of Edinburgh internal ethics committee and was
performed in accordance with the institutional guidelines under license by the
UK Home Office.
Immunohistochemistry
Mice were culled and eyes were enucleated and placed into Davidson’s
fixative for 1 h (cryosectioning) or overnight (wax embedding). For
cryosectioning, eyes were removed from Davidson’s fixative and placed
Fig. 5. Idh3b−/− mice show no signs of retinal
degeneration up to 6 months. Idh3b−/− mice
show no retinal degeneration up to P180.
(A) GFAP green immunofluorescence on retinal
sections shows no upregulation in mutant mice,
indicating the absence of retinal stress (n=3).
(B) ERG analysis of P180 Idh3b−/− in response
to 3 cd/m3 flash under scotopic conditions
shows a similar a-wave amplitude [233.4±19.63
(mean±s.e.m., n=6, F2, M4)] to that of wild-type
littermates [207.7±14.42 (mean±s.e.m., n=6,
F3, M3)] (left). ERG traces of mutant mice (red)
also show no defects when compared with wild
type (black) (right). (C-E) OCR was measured in
Idh3b−/− MEF cells and compared with that of
control littermates. In contrast to Idh3a mutant
cells, Idh3b−/− cells did not show significantly
reduced maximum respiration or spare
respiratory capacity. (F) Western blot analysis for
IDH3B and α-tubulin in retinal tissue shows the
absence of IDH3B protein in Idh3b−/− retinas.
Scale bar: 50 µm.
Table 2. CRISPR guides
Name Sequence
Idh3a_Guide A5 5′-GCATTTAAACATACAGTATCA-3′
Idh3a_Guide B3 5′-GAAGTATGCATCAGTGCTTCC-3′
Idh3b_Guide 1 5′-AGGAAAGATCTATACCCCAATGG-3′
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into 10%, 15% and 20% sucrose in PBS for 15 min, 15 min and overnight,
respectively. Eyes were then embedded using OCT cryopreservant and kept
at −80°C until sectioning. For wax preservation, eyes were removed from
Davidson’s fixative and placed successively into 70%, 80%, 90% and 100%
ethanol, xylene twice and then paraffin each for 45 min.
Haematoxylin and Eosin (H&E) staining was performed on 8 µm paraffin
tissue sections, which were imaged on a Zeiss Axioplan 2 brightfield
microscope. Anti-GFAP antibody (ab7260, Abcam) and Alexa Fluor 488
donkey anti-rabbit antibody (A21206, Invitrogen) were used on 8 µm frozen
sections at 1:100 and 1:300, respectively. Slides were imaged on a Nikon
A1R microscope.
Generation of MEF cells
MEF cells were generated using E12.5-14.5 embryos as described in
Takahashi and Yamanaka (2006), using Gibco Opti-MEM media (Thermo
Fisher Scientific) with 10% fetal calf serum, and grown in hypoxic
conditions (5% CO2, 3% O2). Cells were passaged three times before use,
and littermate controls were used where possible.
ERG
All mice undergoing an ERG were dark adapted for at least 2 h prior to the
procedure, and experiments were carried out in a darkened room under red
light using an HMsERG system (Ocuscience). Mice were anesthetised
using isofluorane, and pupils were dilated through the topical application of
1% w/v tropicamide before being placed on a heated ERG plate. Three
grounding electrodes were used subcutaneously (tail and each cheek) and
silver-embedded electrodes were placed on the cornea, held in place with a
contact lens. A standard ISCEV protocol was used, which recorded scotopic
responses before a 10 min light adaption phase in order to record photopic
responses. Scotopic responses of 3 cd.s/m2 light intensity were used
for analysis.
Extracellular flux analysis
Mitochondrial activity of MEF cells was analysed using the Seahorse
Extracellular Flux Analyser, XFe24 (Agilent) as described in Lee et al.
(2016). Cells were seeded onto a 24-well plate, at 15,000 cells per well, the
day before analysis so cells were 90% confluent at the time of the assay
(mutant cell lines appear to proliferate at the same rate as control cells).
Oxygen consumption (OCR) was measured from cells in XFAssay medium
supplemented with 10 mM glucose and 2 mM pyruvate (pH adjusted to 7.4
at 37°C). After three basal OCR measurements were obtained, OCR was
measured following sequential injection of mitochondrial drugs (three
measurements per drug injection); oligomycin (Port A, 1 µM), FCCP (Port
B, 3.5 µM), antimycin and rotenone (Port C, 1 µM). Each measurement was
derived from the rate of change in oxygen following a standard protocol
(Mix, 3 min; Wait, 2 min; Measure, 3 min). Results were then standardised
to cell number by sulforhodamine B assay, and results were reported by
540 absorption.
Optokinetic reflex measurement
We assessed the visual acuity of the mice in the ENU screen using a virtual
reality optokinetic system manufactured by Cerebral Mechanics, as
described by Douglas et al. (2005). In brief, we observe the head-tracking
response of the mouse to a variable density-moving grating. The mouse is
positioned within a cabinet formed of monitors on which a virtual drum
made of a vertical grating is generated by a computer. The grating density is
varied to determine the point at which the head tracking stops, showing that
the grating is no longer perceived.
Structural analysis
The effects of the missense mutations on the crystal structure of the IDH3α:
IDH3γ heterodimer (PDB ID: 5GRI) (Ma et al., 2017a) were modelled using
the program FoldX (Guerois et al., 2002). The predicted effect on monomer
stability (ΔΔG) was calculated with the FoldX BuildModel function, using
the IDH3A subunit in isolation from the complex. The predicted change in
interaction strength was calculated as the difference between the change in
stability for the heterodimeric complex and that of the monomer.
Western blot
Protein samples were ran on a 4-12% Tris-Bis gel (Invitrogen) and transferred
to a PVDF membrane. Anti-α-tubulin (T5168, Sigma-Aldrich), anti-total
OXPHOS (ab110413, Abcam), anti-IDH3A (15909-1-AP, Proteintech) and
anti-IDH3B (ab121016, Abcam) were all diluted 1:1000 in PBS with 5%
Marvel and incubated overnight at 4°C. Horseradish-peroxidase-conjugated
anti-mouse (NA931V, GE Healthcare Life Sciences), anti-rabbit (NA934V,
GE Healthcare Life Sciences) and anti-goat (sc-2020, Santa Cruz
Biotechnology) antibodies were diluted 1:7000 in PBS with 5% Marvel
and incubated at room temperature for 1 h.
Reactive oxygen species detection
An Image-iT™ LIVE Green Reactive Oxygen Species Detection Kit
(I36007, Invitrogen) was used as per the manufacturer’s instructions. Cells
were imaged using a Nikon A1R microscope, and analysis of fluorescent
levels, normalised to 4′,6-diamidino-2-phenylindole (DAPI) fluorescent
levels, was performed using ImageJ (https://imagej.nih.gov/ij/).
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 Phenotyping Test  Parameter  
Wild Type  Mutant  
P value+  
Mean  SD  n  Mean  SD  n  
Bodyweight (10w)  
Males(g)  32.17  4.80  46  27.92  5.07  5  0.148  
Females (g)  23.47  3.13  45  23.52  4.51  4  0.984  
Echo MRI  
(3 Months, Males)  
Fat (g)  8.7  3.23  45  5.8  2.70  5  0.076  
Lean (g)  24.5  3.01  45  22.5  4.47  5  0.382  
Fat (%)  23.2  6.21  45  18.0  5.41  5  0.101  
Lean (%)  67.5  5.42  45  72.2  6.49  5  0.194  
Bodyweight (22w)  
Males(g)  38.60  6.14  45  34.22  9.00  5  0.349  
Females (g)  35.69  5.90  45  35.37  7.07  4  0.936  
IPGTT (5 months, 
Males)  
Glucose t=0 (mmol/l)  10.2  2.51  45  8.88  1.41  5  0.115  
Glucose t=60 (mmol/l)  26.5  6.90  45  24.12  4.32  5  0.319  
Glucose t=120 (mmol/l)  17.3  5.40  45  13.68  3.08  5  0.058  
Insulin t=0 ( g/l)  1.0  0.40  45  0.875  0.24  5  0.348  
Clinical Chemistry  
(6  months, 
Females)  
Urea (nmol/l)  10.44  3.01  45  8.93  1.21  4  0.085  
Creatinine (µmol/l)  18.19  9.90  45  13.90  4.40  4  0.157  
Calcium (mmol/l)  2.40  0.13  45  2.43  0.06  4  0.439  
ALP (U/l)  89.73  19.52  45  84.40  10.82  4  0.435  
ALT (U/l)  31.18  5.11  45  29.25  2.65  4  0.262  
AST (U/l)  51.21  6.55  45  49.10  9.64  4  0.697  
Albumin (g/l)  33.60  1.93  45  34.90  1.52  4  0.208  
LDH (U/l)  371.99  86.54  45  402.95  68.41  4  0.459  
Amylase (U/l)  595.73  82.96  45  607.35  132.95  4  0.875  
Bodyweight (52w)  Males(g)  46.14  7.85  40  42.72  8.68  5  0.449  
Disease Models & Mechanisms: doi:10.1242/dmm.036426: Supplementary information
Jo
ur
na
l o
f 
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
Females (g)  42.69  8.58  44  38.76  11.28  4  0.546  
Clinical Chemistry  
(12  months, 
Females)  
Urea (nmol/l)  9.07  2.34  45  10.80  2.54  4  0.280  
Creatinine (µmol/l)  13.79  6.70  45  21.65  13.90  4  0.345  
Calcium (mmol/l)  2.36  0.37  45  2.38  0.22  4  0.879  
ALP (U/l)  98.68  31.09  45  85.90  12.80  4  0.157  
ALT (U/l)  37.31  16.45  45  37.20  4.79  4  0.975  
AST (U/l)  61.89  21.77  45  64.95  24.42  4  0.824  
Albumin (g/l)  33.74  5.39  45  36.35  1.67  4  0.048*  
 LDH (U/l)  411.96  220.92  45  877.90  773.73  4  0.316  
Amylase (U/l)  610.81  141.53  45  531.25  112.70  4  0.278  
Bodyweight (78w)  
Males(g)  47.20  7.69  22  41.31  6.36  4  0.175  
Females (g)  46.16  9.84  21  42.44  13.86  4  0.643  
Clinical Chemistry  
(18  months, 
Females)  
Sodium (mmol/l)  150.82  3.70  40  152.50  104.03  4  0.976  
Potassium (mmol/l)  6.32  1.81  40  7.78  3.19  4  0.434  
Chloride (mmol/l)  107.49  2.93  40  109.25  73.93  4  0.965  
Urea (nmol/l)  9.71  1.91  40  8.50  5.52  4  0.962  
Creatinine (µmol/l)  13.41  3.64  40  12.15  6.91  4  0.743  
Calcium (mmol/l)  2.42  0.23  40  2.41  1.55  4  0.991  
Inorganic Phosphate (mmol/l)  2.50  0.87  40  2.93  1.15  4  0.520  
ALP (U/l)  94.62  37.87  40  99.00  40.13  4  0.848  
ALT (U/l)  42.36  30.20  40  37.50  8.59  4  0.463  
AST (U/l)  83.87  46.77  40  70.50  26.23  4  0.415  
Total Protein (g/l)  53.20  3.09  40  53.18  35.43  4  0.999  
Albumin (g/l)  28.41  1.96  40  31.15  18.70  4  0.789  
Total Cholesterol (mmol/l)  4.40  0.96  40  3.73  2.43  4  0.622  
HDL (mmol/l)  2.86  0.58  40  2.48  1.61  4  0.671  
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LDL (mmol/l)  0.91  0.34  40  1.00  0.40  4  0.693  
Glucose (mmol/l)  16.16  5.41  40  14.11  7.60  4  0.635  
Triglycerides (mmol/l)  1.95  0.75  40  1.87  0.85  4  0.868  
Glycerol (µmol/l)  574.51  222.14  40  685.00  249.17  4  0.456  
Free Fatty Acids (mmol/l)  1.22  0.38  40  1.69  0.60  4  0.222  
Total Bilirubin (µmol/l)  2.29  0.42  40  4.28  1.32  4  0.058  
LDH (U/l)  498.79  164.06  40  520.50  236.69  4  0.869  
Amylase (U/l)  608.15  86.25  40  521.75  369.04  4  0.672  
Creatine Kinase (U/I  169.54  160.17  40  219.00  6.63  4  0.060  
Uric Acid (µmol/l)  278.65  134.67  40  380.67  101.81  4  0.138  
Fructosamine (µmol/l)  228.62  44.81  40  173.25  129.97  4  0.459  
 
Table S1 Phenotypic analysis of Idh3aE229K/E229K mice   
No significant differences were observed between mutant mice and their wild type littermates apart from the 12 month Albumin concentration, 
however the mutant mice appear to be within normal levels and this was no longer significant by 18 months. +Unpaired T-test with Welch’s correction,  
* p < 0.05  
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 Mouse Sex MPC Idh3a 
Periphery 
1 
middle 
1 
nerve 
1 nerve2 
middle 
2 
periphery 
2 
1002 M WT MUT 9 9.2 9.4 11.2 10.8 9.4 
1003 M MUT MUT 9 10.6 8.8 9.4 8.2 6.2 
1004 M WT WT 9 12.4 11.4 10 11.2 8.4 
1005 M WT WT 9.6 11.2 10.2 11.4 11.2 9.4 
1006 M WT MUT 9.4 11.6 10.6 11.6 10.6 8.6 
1007 F MUT MUT 6.2 9.2 9.4 8.6 8.8 6.4 
1008 F WT WT 7.2 9.6 10.8 11.2 11.2 8.8 
1009 F WT WT 9.4 11.4 9.8 10.4 11.4 9.8 
1010 F WT MUT 8.8 11.6 10 9.2 11.4 9 
1202 M MUT WT 11.2 12.4 10 10.2 10 10.2 
1203 M MUT WT 8 11.6 11.4 9.4 10.4 9.6 
1204 M WT MUT 11 12.4 10 11.4 11.6 10.2 
1205 M MUT MUT 8 11.4 10.2 11.2 10.4 8.6 
1206 F WT MUT 9.2 12.2 12.8 11.4 10.4 9 
1207 F WT MUT 9.6 10.4 10.2 10.6 10.4 10.2 
1208 F WT WT 9.2 11.2 12.2 10.6 9.2 8.2 
1209 F MUT MUT 7 10.6 10.6 10.6 10 8.8 
1210 F WT WT 7.8 8.2 10.4 11 11 9 
1211 F MUT WT 10 10.4 10.6 10.6 10.8 8.4 
 
Table S2. Outer nuclear layers of offspring of Idh3a E229K/- intercross. WT and MUT indicate wild-type or mutant for the particular allele. Number of 
nuclei in sections through the outer nuclear layer. Each is the mean of 5 counts (technical replicates).  
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 Genotype Average Fluorescence Intensity 
 
Cell line 
1 
Cell line 
2 
Cell line 
3 
Cell line 
4 
+/+ 203.128 263.989 264.796 278.359 
E229K/+ 322.033 294.909 327.883  
-/+ 292.315 262.582 250.29 258.325 
E229K/E229K 230.348 272.818 265.045 222.117 
-/E229K 360 216.375 267.474  
 
Table S3 Reactive Oxygen Species: Data for Figure S3. 3 or 4 cell lines (biological replicates) from each genotype were analysed with measurements in 4 
wells (technical replicates). The means of the technical replicates are shown for each biological replicate. 
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Figure S1 Analysis of Idh3a expression and protein levels in mutant MEF cells 
(A) RNA was isolated from C57BL6/J mice retina and brain and RT-PCR was performed to assay the expression of Idh3 heterotetramer components and 
Idh2 genes.  All were present in all samples. (B) Western blot showing the reduced protein in Idh3a-/+ and Idh3a-/E229K compared to control littermates 
(Idh3a+/+ and Idh3aE229K/E229K) as well as Idh3aE229K/E229K mutant cells.  Alpha-tubulin was used as a loading control. 
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Figure S2 Analysis of Idh3a-/+ mice show no retinal phenotype up to one year 
(A) Idh3a-/+ mice show no upregulation of GFAP at one year, with staining comparable to that of wild type littermates (n = 3). (B) Morphology of retinal 
layers, including the outer nuclear layer, appears normal at 12 months and is comparable to that of wild type littermates (n = 6). (C) Idh3a-/+ mutant 
mice show no reduction in retinal function at one year, exhibiting similar ERG a-wave responses to those of wild type littermates (p = 0.286, n = 4). 
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Figure S3 Further analysis of MEF cell lines 
(A) Reactive Oxygen Species (ROS) were measured in each of the cell lines, both Idh3a-/E229K and Idh3aE229K/E229K cells showed levels similar to that of 
control cells (Idh3a+/+, Idh3a-/+ and Idh3aE229K/+), graph shows fluorescent intensity in arbitrary units Data is in Table S3. (B) Western blot analysis of MEF 
cell lines showing similar levels of mitochondrial proteins; Complex II, Complex IV and Complex V.  Alpha-tubulin was used as a loading control. 
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